Personal tools

Coexpression cluster:C463

From FANTOM5_SSTAR

Revision as of 17:45, 12 September 2012 by Autoedit (talk | contribs)
Jump to: navigation, search


Full id: C463_Mesothelial_mesothelioma_Sertoli_mesenchymal_vagina_Cardiac_Fibroblast



Phase1 CAGE Peaks

Hg19::chr10:6622278..6622290,-p6@PRKCQ
Hg19::chr11:116728907..116728948,+p2@CU690121
Hg19::chr13:38091764..38091775,+p@chr13:38091764..38091775
+
Hg19::chr13:38145825..38145840,-p14@POSTN
Hg19::chr13:38148733..38148753,-p@chr13:38148733..38148753
-
Hg19::chr13:97328912..97328917,+p@chr13:97328912..97328917
+
Hg19::chr1:22469560..22469567,-p3@WNT4
Hg19::chr20:6033732..6033760,-p8@AB527789
Hg19::chr20:6034216..6034224,-p@chr20:6034216..6034224
-
Hg19::chr20:6034506..6034518,-p4@LRRN4
Hg19::chr20:61687988..61688007,-p@chr20:61687988..61688007
-
Hg19::chr20:8101412..8101426,+p@chr20:8101412..8101426
+
Hg19::chr20:8101451..8101452,+p@chr20:8101451..8101452
+
Hg19::chr2:10454550..10454555,+p@chr2:10454550..10454555
+
Hg19::chr2:220309299..220309306,+p32@SPEG
Hg19::chr3:158450428..158450431,-p9@RARRES1
Hg19::chr3:158450447..158450473,-p4@RARRES1
Hg19::chr3:158450475..158450494,-p6@RARRES1
Hg19::chr3:180707620..180707631,-p3@DNAJC19
Hg19::chr4:146267392..146267393,-p@chr4:146267392..146267393
-
Hg19::chr8:140663726..140663732,-p@chr8:140663726..140663732
-


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data


GO IDGO nameFDR corrected p-value
GO:0032502developmental process0.00688389882661927
GO:0048856anatomical structure development0.0111239349841107
GO:0007275multicellular organismal development0.0126389772157664
GO:0008285negative regulation of cell proliferation0.0189097449991574
GO:0048513organ development0.0189097449991574
GO:0048731system development0.0285564188245063
GO:0032501multicellular organismal process0.0285564188245063
GO:0048806genitalia development0.0285564188245063
GO:0005578proteinaceous extracellular matrix0.0285564188245063
GO:0043681protein import into mitochondrion0.0285564188245063
GO:0004697protein kinase C activity0.0285564188245063
GO:0001565phorbol ester receptor activity0.0285564188245063
GO:0042127regulation of cell proliferation0.0285564188245063



Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>


Uber Anatomy
Ontology termp-valuen
epithelial tube6.06e-12118
trunk mesenchyme6.66e-11143
multi-tissue structure1.99e-09347
muscle tissue5.38e-0963
musculature5.38e-0963
musculature of body5.38e-0963
compound organ7.53e-0969
trunk1.04e-08216
anatomical cluster1.33e-08286
cell layer1.62e-08312
skeletal muscle tissue2.54e-0861
striated muscle tissue2.54e-0861
myotome2.54e-0861
epithelium4.25e-08309
anatomical conduit5.46e-08241
unilaminar epithelium8.09e-08138
primary circulatory organ1.21e-0727
tube1.63e-07194
mesenchyme2.37e-07238
entire embryonic mesenchyme2.37e-07238
splanchnic layer of lateral plate mesoderm3.34e-0784
heart5.28e-0724
primitive heart tube5.28e-0724
primary heart field5.28e-0724
anterior lateral plate mesoderm5.28e-0724
heart tube5.28e-0724
heart primordium5.28e-0724
cardiac mesoderm5.28e-0724
cardiogenic plate5.28e-0724
heart rudiment5.28e-0724
systemic artery6.90e-0733
systemic arterial system6.90e-0733


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs



JASPAR motifs

Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data


No analysis results for this cluster

Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data


This analysis result is provided for C0 - C305 clusters.